Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Issues New Stock To Fund Expansion, Hardware Purchases


PALO ALTO, Calif.--Incyte Pharmaceuticals here, a leading genomic database company, has issued 1.2 million new shares of stock to finance the purchase of additional computer hardware, expansion of the company's facilities, and other capital requirements, as well as to pursue strategic investments. The stock sold for $67 per share.

Incyte offers products including the LifeSeq and PathSeq database families that integrate bioinformatics software with both proprietary and public genetic data to create tools for drug discovery and development. It also sells the LifeTools line of bioinformatics software.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.